FULC Fulcrum Therapeutics, Inc.
$3.79
Fulcrum Therapeutics, Inc. (FULC) SEC Filings
Everything FULC has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.
| Date | Form | Filing |
|---|---|---|
| 144 | View filing | |
| 8-K Acquisition Disposition · Capital Raise · Dilution · Executive Change · Investor Presentation · Material Agreement · Reg Fd | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4/A | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing |
Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.